Gene Editing Could Modify And Cure Disease: CRISPR Vs. TALENsSeeking AlphaRecently, many scientists have proclaimed that CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is the breakthrough technology in genome modification. In 2016 a… Continue reading
|
‘Labyrinth’ chip could help monitor aggressive cancer stem cells
Medical Xpress Cancer stem cells are fluid in their gene expression, transitioning from stem-like cells that are good at surviving in the blood to more ordinary cell types that are better at growing and dividing. Conventional cell targeting, by grabbing proteins … |
|
OHSU gene therapy pioneer Shoukhrat Mitalipov headlines Health Care of the Future event
Portland Business Journal Speakers include OHSU’s Dr. Shoukhrat Mitalipov, whose groundbreaking work on gene mutations is getting global recognition; OHSU’s SVP for research Daniel Dorsa; IBM Watson Health’s VP of global partnerships Kathy McGroddy-Goetz; Intel’s global … |
University of Florida |
Unique gene therapy prevents, reverses multiple sclerosis in animal model
University of Florida Multiple sclerosis can be inhibited or reversed using a novel gene therapy technique that stops the disease’s immune response in mouse models, University of Florida Health researchers have found. By combining a brain-protein gene and an existing … Gene Therapy Treats and Reverses MS Symptoms in Mouse ModelTechnology Networks |
Laboratory Equipment |
UK Scientists Use CRISPR to Study Gene Function in Human Embryos
Laboratory Equipment Using CRISPR-Cas9, the researchers “turned off” the gene that produces OCT4 and observed what happened to 41 embryo development over the next seven days. The embryos used for the study were donated from couples who had a surplus after IVF … CRISPR used to peer into human embryos’ first daysNature.com Fertility “Master Gene” Identified In Groundbreaking CRISPR ResearchIFLScience CRISPR Used in Human Embryos to Probe Gene FunctionThe Scientist Futurism –GenomeWeb –TIME –MedlinePlus all 66 news articles » |
R & D Magazine |
CRISPR Field – Patent Fight Extended: Focus On Science, Time Frames, Risks
Seeking Alpha Outside of venture capital meetings and scientific forums on the topic, the idea of CRISPR is poorly understood and looked at with a mix of concern and awe at what it may allow the scientific and medical community to do. In looking at the focus of … Researchers in US improve accuracy of CRISPR-Cas9 gene-editing toolXinhua |